Korea Made Humira Biosimilar Begins Sales in Australia, Marks its Presence in Third Overseas Market
After launching in Canada in February, Korea’s Samsung Bioepis began selling HUMIRA’s biosimilar HADLIMA (adalimumab) in Australia in partnership with MSD Australia (Merck & Co. in the U.S. and Canada). …
Read More